Pub Date : 2025-09-30eCollection Date: 2025-09-01DOI: 10.5114/kitp.2025.154844
Piotr Gabryel, Dominika Zielińska, Lidia Szlanga, Alicja Werblińska, Jakub Woźniak, Maciej Bryl, Cezary Piwkowski
Lung cancer remains a major health challenge despite recent advances in diagnostics and treatment. Surgical resection, particularly in early stages, offers the best chance for cure. Enhanced Recovery After Surgery (ERAS) programs have been shown to improve outcomes in various surgical areas. This narrative review summarizes current evidence on the role of prehabilitation within ERAS for lung cancer surgery and presents the organizational model from a high-volume academic thoracic surgery center. Key elements of prehabilitation include smoking cessation, nutritional optimization, physical activity enhancement, and patient education, all delivered by a multidisciplinary team. Despite organizational challenges, preoperative ERAS programs demonstrate benefits for patients and hospitals, supporting their broader implementation in thoracic surgery.
{"title":"Prehabilitation as a key component of the Enhanced Recovery After Surgery (ERAS) program in patients with lung cancer: a narrative review.","authors":"Piotr Gabryel, Dominika Zielińska, Lidia Szlanga, Alicja Werblińska, Jakub Woźniak, Maciej Bryl, Cezary Piwkowski","doi":"10.5114/kitp.2025.154844","DOIUrl":"10.5114/kitp.2025.154844","url":null,"abstract":"<p><p>Lung cancer remains a major health challenge despite recent advances in diagnostics and treatment. Surgical resection, particularly in early stages, offers the best chance for cure. Enhanced Recovery After Surgery (ERAS) programs have been shown to improve outcomes in various surgical areas. This narrative review summarizes current evidence on the role of prehabilitation within ERAS for lung cancer surgery and presents the organizational model from a high-volume academic thoracic surgery center. Key elements of prehabilitation include smoking cessation, nutritional optimization, physical activity enhancement, and patient education, all delivered by a multidisciplinary team. Despite organizational challenges, preoperative ERAS programs demonstrate benefits for patients and hospitals, supporting their broader implementation in thoracic surgery.</p>","PeriodicalId":49945,"journal":{"name":"Kardiochirurgia I Torakochirurgia Polska","volume":"22 3","pages":"206-211"},"PeriodicalIF":1.3,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12670226/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145670805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-30eCollection Date: 2025-09-01DOI: 10.5114/kitp.2025.154929
Vasileios Leivaditis, Elias Liolis, Nikolaos Baltayiannis, Pavlos Sarof, Alexandra Pagoulatou, Konstantinos Grapatsas, Andreas Antzoulas, Dimitrios Litsas, Panagiotis Dimitrios Papadopoulos, George Theofanis, Konstantinos Nikolakopoulos, Paraskevi Katsakiori, Athanasios Papatriantafyllou, Efstratios Koletsis, Marina Michalaki, Francesk Mulita
A goiter is defined as an enlargement of the thyroid gland, typically resulting in a doubling in size or a weight exceeding 40 g. It affects approximately 5% of the global population. Diving, or substernal, goiters occur when more than 50% of the thyroid extends into the mediastinum, with an incidence ranging from 5% to 15.7% across various studies. An alternative definition describes diving goiters as those extending more than 3 cm below the sternal notch on chest computed tomography with the neck in hyperextension, or beyond the fourth thoracic vertebra. In this review, we outline the key clinical and radiological criteria that indicate when sternotomy is required for the surgical management of diving goiters.
{"title":"Diving retrosternal goiter and the dilemma of sternotomy: indications, predictors and surgical considerations.","authors":"Vasileios Leivaditis, Elias Liolis, Nikolaos Baltayiannis, Pavlos Sarof, Alexandra Pagoulatou, Konstantinos Grapatsas, Andreas Antzoulas, Dimitrios Litsas, Panagiotis Dimitrios Papadopoulos, George Theofanis, Konstantinos Nikolakopoulos, Paraskevi Katsakiori, Athanasios Papatriantafyllou, Efstratios Koletsis, Marina Michalaki, Francesk Mulita","doi":"10.5114/kitp.2025.154929","DOIUrl":"10.5114/kitp.2025.154929","url":null,"abstract":"<p><p>A goiter is defined as an enlargement of the thyroid gland, typically resulting in a doubling in size or a weight exceeding 40 g. It affects approximately 5% of the global population. Diving, or substernal, goiters occur when more than 50% of the thyroid extends into the mediastinum, with an incidence ranging from 5% to 15.7% across various studies. An alternative definition describes diving goiters as those extending more than 3 cm below the sternal notch on chest computed tomography with the neck in hyperextension, or beyond the fourth thoracic vertebra. In this review, we outline the key clinical and radiological criteria that indicate when sternotomy is required for the surgical management of diving goiters.</p>","PeriodicalId":49945,"journal":{"name":"Kardiochirurgia I Torakochirurgia Polska","volume":"22 3","pages":"174-181"},"PeriodicalIF":1.3,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12670237/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145670795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-30eCollection Date: 2025-09-01DOI: 10.5114/kitp.2025.154842
Hari Govind Varma, Digvijay Gowda, Susovan Halder, Pritish K Nayak, Lalit Kapoor
{"title":"Redo aortic valve replacement with the Perceval valve: the ideal stepping stone in the lifetime management of aortic stenosis?","authors":"Hari Govind Varma, Digvijay Gowda, Susovan Halder, Pritish K Nayak, Lalit Kapoor","doi":"10.5114/kitp.2025.154842","DOIUrl":"10.5114/kitp.2025.154842","url":null,"abstract":"","PeriodicalId":49945,"journal":{"name":"Kardiochirurgia I Torakochirurgia Polska","volume":"22 3","pages":"212-215"},"PeriodicalIF":1.3,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12670234/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145670868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-30eCollection Date: 2025-09-01DOI: 10.5114/kitp.2025.154888
Shukur Musayev, Volkan Karacam, Pınar A Yılmaz, Kemal C Tertemiz, Meltem Sevinç, Bekir U Ergur, Aydın Sanlı, Nezih Ozdemir
Introduction: Pulmonary contusion leads to alveolar damage and inflammation, which can progress to acute lung injury and acute respiratory distress syndrome. Glutamine and L-arginine play critical roles in immune regulation and inflammation control, showing potential protective effects in lung injury models.
Aim: This study aimed to investigate the effects of glutamine and/or arginine, which play significant roles in the immuno-inflammatory response, on mitigating inflammation in an experimentally induced pulmonary contusion model.
Material and methods: Thirty male Wistar Albino rats from the same colony were randomly divided into five groups (n = 6 per group). Group I (sham) received no trauma or treatment. Bilateral pulmonary contusion was induced in Groups II-V. Group II received 0.9% saline; Group III received 200 mg/kg/day intraperitoneal glutamine; Group IV received 200 mg/kg/day intraperitoneal arginine; and Group V received both glutamine (200 mg/kg/day) and arginine (150 mg/kg/day). All treatments were administered for 3 consecutive days. Rats were sacrificed three days after the procedure, and histopathologic evaluation was performed afterwards. Three different parameters were scored: inflammation intensity, intraalveolar hemorrhage, and alveolar congestion. Statistical analysis was performed using the Mann-Whitney U test.
Results: Compared to the untreated trauma group, all treatment groups showed significant histopathological improvement (p < 0.05). The arginine-only group demonstrated greater effectiveness across all parameters compared to the combined treatment group (p < 0.05). No significant difference was observed between the glutamine-only and arginine-only groups (p > 0.05).
Conclusions: Both glutamine and arginine treatments were effective in reducing inflammation following pulmonary contusion. However, combined treatment was less effective than arginine alone.
{"title":"Effect of glutamine and arginine treatment on the inflammatory response in a rat model of pulmonary contusion.","authors":"Shukur Musayev, Volkan Karacam, Pınar A Yılmaz, Kemal C Tertemiz, Meltem Sevinç, Bekir U Ergur, Aydın Sanlı, Nezih Ozdemir","doi":"10.5114/kitp.2025.154888","DOIUrl":"10.5114/kitp.2025.154888","url":null,"abstract":"<p><strong>Introduction: </strong>Pulmonary contusion leads to alveolar damage and inflammation, which can progress to acute lung injury and acute respiratory distress syndrome. Glutamine and L-arginine play critical roles in immune regulation and inflammation control, showing potential protective effects in lung injury models.</p><p><strong>Aim: </strong>This study aimed to investigate the effects of glutamine and/or arginine, which play significant roles in the immuno-inflammatory response, on mitigating inflammation in an experimentally induced pulmonary contusion model.</p><p><strong>Material and methods: </strong>Thirty male Wistar Albino rats from the same colony were randomly divided into five groups (<i>n</i> = 6 per group). Group I (sham) received no trauma or treatment. Bilateral pulmonary contusion was induced in Groups II-V. Group II received 0.9% saline; Group III received 200 mg/kg/day intraperitoneal glutamine; Group IV received 200 mg/kg/day intraperitoneal arginine; and Group V received both glutamine (200 mg/kg/day) and arginine (150 mg/kg/day). All treatments were administered for 3 consecutive days. Rats were sacrificed three days after the procedure, and histopathologic evaluation was performed afterwards. Three different parameters were scored: inflammation intensity, intraalveolar hemorrhage, and alveolar congestion. Statistical analysis was performed using the Mann-Whitney <i>U</i> test.</p><p><strong>Results: </strong>Compared to the untreated trauma group, all treatment groups showed significant histopathological improvement (<i>p</i> < 0.05). The arginine-only group demonstrated greater effectiveness across all parameters compared to the combined treatment group (<i>p</i> < 0.05). No significant difference was observed between the glutamine-only and arginine-only groups (<i>p</i> > 0.05).</p><p><strong>Conclusions: </strong>Both glutamine and arginine treatments were effective in reducing inflammation following pulmonary contusion. However, combined treatment was less effective than arginine alone.</p>","PeriodicalId":49945,"journal":{"name":"Kardiochirurgia I Torakochirurgia Polska","volume":"22 3","pages":"158-162"},"PeriodicalIF":1.3,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12670224/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145670870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-30eCollection Date: 2025-09-01DOI: 10.5114/kitp.2025.155459
Mariusz Kowalewski, Michał Farkowski, Jakub Batko, Natalia Ogorzelec, Michał Zembala, Oskar Kowalski, Sebastian S Aboul-Hassan, Rafał Płaksej, Piotr Buchta, Grzegorz Hirnle, Marek Jastrzębski, Agnieszka Wojdyła-Hordyńska, Krzysztof Bartus, Marek A Deja, Marek Jasiński, Tomasz Hrapkowicz, Bohdan Maruszewski, Janusz Skalski, Kazimierz Widenka, Piotr Kułakowski, Agnieszka Tycińska, Robert J Gil, Sebastian Stec, Adam Sokal, Piotr Suwalski
This position paper, jointly authored by the Polish Society of Cardiothoracic Surgeons and the Heart Rhythm Association of the Polish Society of Cardiology, defines the role of hybrid approaches in the treatment of cardiac arrhythmias, particularly atrial fibrillation. We present a rationale for integrating epicardial and endocardial ablation strategies, summarize current evidence, and advocate for multidisciplinary planning, including arrhythmia treatment during cardiac surgery for other indications and atrial fibrillation treatment as a stand-alone procedure. The paper highlights the importance of minimally invasive approaches, the need for heart team-based planning, structured curricula, and postoperative referral pathways for comprehensive management of atrial fibrillation and non-atrial fibrillation arrhythmias.
{"title":"Position paper of the Polish Society of Cardiothoracic Surgeons and the Heart Rhythm Association of the Polish Society of Cardiology on atrial fibrillation hybrid management.","authors":"Mariusz Kowalewski, Michał Farkowski, Jakub Batko, Natalia Ogorzelec, Michał Zembala, Oskar Kowalski, Sebastian S Aboul-Hassan, Rafał Płaksej, Piotr Buchta, Grzegorz Hirnle, Marek Jastrzębski, Agnieszka Wojdyła-Hordyńska, Krzysztof Bartus, Marek A Deja, Marek Jasiński, Tomasz Hrapkowicz, Bohdan Maruszewski, Janusz Skalski, Kazimierz Widenka, Piotr Kułakowski, Agnieszka Tycińska, Robert J Gil, Sebastian Stec, Adam Sokal, Piotr Suwalski","doi":"10.5114/kitp.2025.155459","DOIUrl":"10.5114/kitp.2025.155459","url":null,"abstract":"<p><p>This position paper, jointly authored by the Polish Society of Cardiothoracic Surgeons and the Heart Rhythm Association of the Polish Society of Cardiology, defines the role of hybrid approaches in the treatment of cardiac arrhythmias, particularly atrial fibrillation. We present a rationale for integrating epicardial and endocardial ablation strategies, summarize current evidence, and advocate for multidisciplinary planning, including arrhythmia treatment during cardiac surgery for other indications and atrial fibrillation treatment as a stand-alone procedure. The paper highlights the importance of minimally invasive approaches, the need for heart team-based planning, structured curricula, and postoperative referral pathways for comprehensive management of atrial fibrillation and non-atrial fibrillation arrhythmias.</p>","PeriodicalId":49945,"journal":{"name":"Kardiochirurgia I Torakochirurgia Polska","volume":"22 3","pages":"143-157"},"PeriodicalIF":1.3,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12670236/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145670880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This article reviews the progress of nanoparticles as drug carriers in the treatment of cardiovascular diseases, and how nanoparticles can deliver anti-inflammatory, anti-proliferative, and anticoagulant drugs directly to the surgical site in surgical procedures. For this, 45 articles published between 2005 and 2024 with keywords including "Artificial intelligence Nanoparticle", "Emergency Medicine Unit", and "Therapeutic for the treatment of cardiovascular diseases" in Scopus, Elsevier, Web of Science and ScienceDirect were reviewed. Nanoparticle-based drug delivery systems have demonstrated several noteworthy therapeutic benefits in the treatment of cardiovascular disorders since they were first used in the cancer field to deliver safer and more effective chemotherapeutics. By delivering targeted and site-specific medications with controlled release, nanoparticle-based drug delivery systems modify the biodistribution of therapeutic agents. An optimal material for cardiovascular therapeutics would be a nanoparticle based on metal, lipid, or polymer.
本文综述了纳米颗粒作为药物载体在心血管疾病治疗中的进展,以及纳米颗粒如何在外科手术中将抗炎、抗增殖和抗凝血药物直接输送到手术部位。为此,我们回顾了2005年至2024年间在Scopus、Elsevier、Web of Science和ScienceDirect上发表的45篇论文,关键词包括“人工智能纳米粒子”、“急诊医学单元”和“治疗心血管疾病”。纳米颗粒为基础的药物输送系统在心血管疾病的治疗中表现出了几个值得注意的治疗效益,因为它们首次用于癌症领域,提供更安全、更有效的化疗药物。纳米颗粒为基础的药物传递系统通过控释靶向和特定部位的药物,改变了治疗剂的生物分布。用于心血管治疗的最佳材料将是基于金属、脂质或聚合物的纳米颗粒。
{"title":"Artificial intelligence nanoparticle-based drug delivery systems and targeted delivery of therapeutics for the treatment of cardiovascular diseases: a systematic review.","authors":"Fatemeh Kamali, Seyedehmahrokh Moosavimordghafari, Mohammad Ghasemian, Narges Kamali, Seyedeh Mahta Mojab, Fatemeh Nikfard, Zahra Nikfard, Saber Bakhtiaryfar","doi":"10.5114/kitp.2025.154852","DOIUrl":"10.5114/kitp.2025.154852","url":null,"abstract":"<p><p>This article reviews the progress of nanoparticles as drug carriers in the treatment of cardiovascular diseases, and how nanoparticles can deliver anti-inflammatory, anti-proliferative, and anticoagulant drugs directly to the surgical site in surgical procedures. For this, 45 articles published between 2005 and 2024 with keywords including \"Artificial intelligence Nanoparticle\", \"Emergency Medicine Unit\", and \"Therapeutic for the treatment of cardiovascular diseases\" in Scopus, Elsevier, Web of Science and ScienceDirect were reviewed. Nanoparticle-based drug delivery systems have demonstrated several noteworthy therapeutic benefits in the treatment of cardiovascular disorders since they were first used in the cancer field to deliver safer and more effective chemotherapeutics. By delivering targeted and site-specific medications with controlled release, nanoparticle-based drug delivery systems modify the biodistribution of therapeutic agents. An optimal material for cardiovascular therapeutics would be a nanoparticle based on metal, lipid, or polymer.</p>","PeriodicalId":49945,"journal":{"name":"Kardiochirurgia I Torakochirurgia Polska","volume":"22 3","pages":"182-189"},"PeriodicalIF":1.3,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12670229/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145670721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-30eCollection Date: 2025-09-01DOI: 10.5114/kitp.2025.154849
Magdalena Synak, Mateusz Hulbój, Witold Gerber, Paweł Kaźimierczak, Piotr P Buszman, Krzysztof Sanetra
Introduction: Hybrid coronary revascularization (HCR) is a combined approach for multivessel coronary artery disease (MVD), integrating surgical grafting of the left internal mammary artery (LIMA) to the left anterior descending artery (LAD) with percutaneous coronary intervention (PCI) for non-LAD lesions. It aims to reduce invasiveness while maintaining effectiveness.
Aim: To summarize current evidence on the safety, effectiveness, and clinical outcomes of HCR compared to coronary artery bypass grafting (CABG), PCI, and off-pump coronary artery bypass (OPCAB).
Methods: A review of current literature including clinical trials, meta-analyses, and observational studies was conducted. Focus was placed on procedural techniques, patient selection, and outcomes.
Results: HCR is associated with shorter hospital stays, reduced bleeding, and faster recovery compared to CABG. Compared to PCI, it shows improved LAD patency and fewer repeat interventions. Outcomes are similar to OPCAB, with lower myocardial injury. Despite its benefits, HCR remains underused due to technical demands and limited availability of hybrid facilities.
Conclusions: Further randomized trials are needed to confirm its long-term safety, effectiveness, and cost-efficiency.
{"title":"Current trends in hybrid coronary revascularization.","authors":"Magdalena Synak, Mateusz Hulbój, Witold Gerber, Paweł Kaźimierczak, Piotr P Buszman, Krzysztof Sanetra","doi":"10.5114/kitp.2025.154849","DOIUrl":"10.5114/kitp.2025.154849","url":null,"abstract":"<p><strong>Introduction: </strong>Hybrid coronary revascularization (HCR) is a combined approach for multivessel coronary artery disease (MVD), integrating surgical grafting of the left internal mammary artery (LIMA) to the left anterior descending artery (LAD) with percutaneous coronary intervention (PCI) for non-LAD lesions. It aims to reduce invasiveness while maintaining effectiveness.</p><p><strong>Aim: </strong>To summarize current evidence on the safety, effectiveness, and clinical outcomes of HCR compared to coronary artery bypass grafting (CABG), PCI, and off-pump coronary artery bypass (OPCAB).</p><p><strong>Methods: </strong>A review of current literature including clinical trials, meta-analyses, and observational studies was conducted. Focus was placed on procedural techniques, patient selection, and outcomes.</p><p><strong>Results: </strong>HCR is associated with shorter hospital stays, reduced bleeding, and faster recovery compared to CABG. Compared to PCI, it shows improved LAD patency and fewer repeat interventions. Outcomes are similar to OPCAB, with lower myocardial injury. Despite its benefits, HCR remains underused due to technical demands and limited availability of hybrid facilities.</p><p><strong>Conclusions: </strong>Further randomized trials are needed to confirm its long-term safety, effectiveness, and cost-efficiency.</p>","PeriodicalId":49945,"journal":{"name":"Kardiochirurgia I Torakochirurgia Polska","volume":"22 3","pages":"190-198"},"PeriodicalIF":1.3,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12670225/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145670762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-30eCollection Date: 2025-09-01DOI: 10.5114/kitp.2025.154986
Adam Mitręga, Dominika Kaczyńska, Mikołaj Magiera, Natalia Denisiewicz, Michał Bielówka, Anna Kożuch, Miłosz Korbaś, Aleksandra Gaweł, Jakub Kufel
Introduction: The incredibly rapid development of artificial intelligence (AI) in recent years has created new opportunities for its application in medical advancements. This raises questions about the reliability and limitations of AI.
Aim: The aim of the present study was to evaluate the effectiveness of the ChatGPT-3.5 language model in solving the test component of the National Specialist Examination (PES) in the field of thoracic surgery.
Material and methods: A total of 120 test questions from 2015 PES examination were analyzed. They were grouped according to subject matter, clinical character, and cognitive requirements. In independent sessions, each question was submitted five times. The following statistical tests were applied: χ2, Kruskal-Wallis, Mann-Whitney and Spearman's rank correlation. The consistency of the answers was assessed using Fleiss' k coefficient.
Results: The AI tool achieved a score of 42.2% correct answers, with the passing threshold set at 60%. A statistically significant difference was found between clinical and non-clinical questions (p = 0.041). Correct answers were characterized by a higher confidence coefficient (p < 0.001). No correlation was observed between confidence and psychometric indicators. The response consistency was assessed as moderate (k = 0.341).
Conclusions: The result obtained by ChatGPT-3.5 is equivalent to a failing score on the examination. The confidence of responses correlated with their correctness, whereas limitations in clinical knowledge and consistency indicate the need for caution when using this model to assess specialized knowledge.
{"title":"ChatGPT-3.5 and the Polish thoracic surgery specialty examination: a performance evaluation.","authors":"Adam Mitręga, Dominika Kaczyńska, Mikołaj Magiera, Natalia Denisiewicz, Michał Bielówka, Anna Kożuch, Miłosz Korbaś, Aleksandra Gaweł, Jakub Kufel","doi":"10.5114/kitp.2025.154986","DOIUrl":"10.5114/kitp.2025.154986","url":null,"abstract":"<p><strong>Introduction: </strong>The incredibly rapid development of artificial intelligence (AI) in recent years has created new opportunities for its application in medical advancements. This raises questions about the reliability and limitations of AI.</p><p><strong>Aim: </strong>The aim of the present study was to evaluate the effectiveness of the ChatGPT-3.5 language model in solving the test component of the National Specialist Examination (PES) in the field of thoracic surgery.</p><p><strong>Material and methods: </strong>A total of 120 test questions from 2015 PES examination were analyzed. They were grouped according to subject matter, clinical character, and cognitive requirements. In independent sessions, each question was submitted five times. The following statistical tests were applied: χ<sup>2</sup>, Kruskal-Wallis, Mann-Whitney and Spearman's rank correlation. The consistency of the answers was assessed using Fleiss' k coefficient.</p><p><strong>Results: </strong>The AI tool achieved a score of 42.2% correct answers, with the passing threshold set at 60%. A statistically significant difference was found between clinical and non-clinical questions (<i>p</i> = 0.041). Correct answers were characterized by a higher confidence coefficient (<i>p</i> < 0.001). No correlation was observed between confidence and psychometric indicators. The response consistency was assessed as moderate (k = 0.341).</p><p><strong>Conclusions: </strong>The result obtained by ChatGPT-3.5 is equivalent to a failing score on the examination. The confidence of responses correlated with their correctness, whereas limitations in clinical knowledge and consistency indicate the need for caution when using this model to assess specialized knowledge.</p>","PeriodicalId":49945,"journal":{"name":"Kardiochirurgia I Torakochirurgia Polska","volume":"22 3","pages":"169-173"},"PeriodicalIF":1.3,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12670230/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145670771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}